InvestorsHub Logo
Followers 80
Posts 24708
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 08/16/2017 8:22:29 AM

Wednesday, August 16, 2017 8:22:29 AM

Post# of 27626
TROV - .80 Pre-market now at .84/.90

Trovagene's PLK1 Inhibitor PCM-075, in Preclinical AML Data, Significantly Enhances the Efficacy of a FLT3 inhibitor in Combination Therapy



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.